Please login to the form below

Not currently logged in


This page shows the latest secukinumab news and features for those working in and with pharma, biotech and healthcare.

Lilly psoriasis drug beats J&J's Tremfya in head-to-head trial

Lilly psoriasis drug beats J&J's Tremfya in head-to-head trial

A successful head-to-head trial against Novartis’ Cosentyx (secukinumab) established Tremfya as a contender in the congested field of psoriasis drugs, but it may now be saddled with the unfavourable

Latest news

More from news
Approximately 15 fully matching, plus 68 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...